New 375 million euro diabetes centre in Copenhagen
11 September 2015
The Novo Nordisk Foundation and the Capital Region of Denmark will establish a globally leading, major new diabetes centre for treatment and clinical research in Copenhagen.
The new Steno Diabetes Center Copenhagen will be a specialist clinic focusing on patient needs and coherent treatment and disease prevention for all types of diabetes and its complications. The centre will have the capacity to treat more than 11,000 people with all types of diabetes annually and will provide 24-hour coverage.
The Novo Nordisk Foundation is making the new centre possible by a grant of up to Euro 375 million (DKK 2.8 billion) from now until 2029. The grant is the Foundation’s largest single award to date.
The new centre will collaborate with hospitals, universities and other public and private sector parties in Denmark and abroad to create one of the leading global environments for the treatment of diabetes and clinical research.
“This is a unique opportunity to establish a world-class diabetes centre in Copenhagen because the Capital Region of Denmark already has high-level research and treatment environments. Further, the size and treatment competence of the new centre means that it will be able to offer people with different types of diabetes coherent treatment of the highest quality,” said Sten Scheibye, Chair of the Novo Nordisk Foundation.
Maybe you will also like: Denmark has more than 200 open life science jobs.